A Study of Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR)
Clinical trial NCT00891735 · COMPLETED
Trial details
- NCT number
- NCT00891735
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2011-08-01
- Enrollment
- 1097
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.